{"&cites=850359239650293226&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Managerial research on the pharmaceutical supply chain–A critical review and some insights for future directions","url":"https://www.sciencedirect.com/science/article/pii/S1478409213000770","authors":["SA Narayana","SA Narayana RK Pati","SA Narayana RK Pati P Vrat"],"year":2014,"numCitations":135,"pdf":"http://dspace.iimk.ac.in/bitstream/handle/2259/456/Article%20%2815%29.pdf?sequence=1&isAllowed=y","citationUrl":"http://scholar.google.com/scholar?cites=9781482354962957200&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:kINRmGDOvocJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9781482354962957200&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier","p":1,"exp":1596890267185},{"title":"A supply chain generalized network oligopoly model for pharmaceuticals under brand differentiation and perishability","url":"https://www.sciencedirect.com/science/article/pii/S1366554512000105","authors":["AH Masoumi","AH Masoumi M Yu","AH Masoumi M Yu A Nagurney"],"year":2012,"numCitations":123,"pdf":"http://supernet.isenberg.umass.edu/visuals/Pharmaceutical_Masoumi_Yu_Nagurney(POMS2012).pdf","citationUrl":"http://scholar.google.com/scholar?cites=7782876900535367139&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:4_UAO05VAmwJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7782876900535367139&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"A robust possibilistic programming approach for pharmaceutical supply chain network design","url":"https://www.sciencedirect.com/science/article/pii/S0098135415002203","authors":["M Mousazadeh","M Mousazadeh SA Torabi","M Mousazadeh SA Torabi B Zahiri"],"year":2015,"numCitations":101,"citationUrl":"http://scholar.google.com/scholar?cites=3129584411054397911&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:11l_y3CEbisJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3129584411054397911&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Addressing antibiotic abuse in China: an experimental audit study","url":"https://www.sciencedirect.com/science/article/pii/S0304387814000704","authors":["J Currie","J Currie W Lin","J Currie W Lin J Meng"],"year":2014,"numCitations":86,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776334/","citationUrl":"http://scholar.google.com/scholar?cites=14241466194344794922&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Ktunmgzao8UJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14241466194344794922&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"WHO guideline on country pharmaceutical pricing policies","url":"https://apps.who.int/iris/bitstream/handle/10665/153920/9789241549035_eng.pdf","authors":["World Health Organization"],"year":2015,"numCitations":86,"pdf":"https://apps.who.int/iris/bitstream/handle/10665/153920/9789241549035_eng.pdf","citationUrl":"http://scholar.google.com/scholar?cites=17239944865780227989&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:lV8mqIOWQO8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17239944865780227989&hl=en&as_sdt=2005&sciodt=0,5","publication":"apps.who.int"},{"title":"Evaluation, in three provinces, of the introduction and impact of China's National Essential Medicines Scheme","url":"https://www.scielosp.org/article/bwho/2013.v91n3/184-194/","authors":["Y Li","Y Li C Ying","Y Li C Ying G Sufang","Y Li C Ying G Sufang P Brant","Y Li C Ying G Sufang P Brant L Bin…"],"year":2013,"numCitations":72,"pdf":"https://www.scielosp.org/article/bwho/2013.v91n3/184-194/","citationUrl":"http://scholar.google.com/scholar?cites=16943461651388461331&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:E3F2BJpEI-sJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16943461651388461331&hl=en&as_sdt=2005&sciodt=0,5","publication":"SciELO Public Health"},{"title":"Health governance and healthcare reforms in China","url":"https://academic.oup.com/heapol/article-abstract/29/6/663/570318","authors":["M Ramesh","M Ramesh X Wu","M Ramesh X Wu AJ He"],"year":2014,"numCitations":75,"pdf":"https://academic.oup.com/heapol/article-pdf/29/6/663/1526219/czs109.pdf","citationUrl":"http://scholar.google.com/scholar?cites=7391681522138098357&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:tSrcey6HlGYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7391681522138098357&hl=en&as_sdt=2005&sciodt=0,5","publication":"academic.oup.com"},{"title":"Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China","url":"https://www.sciencedirect.com/science/article/pii/S2214109X1370072X","authors":["Y Fang","Y Fang AK Wagner","Y Fang AK Wagner S Yang","Y Fang AK Wagner S Yang M Jiang","Y Fang AK Wagner S Yang M Jiang F Zhang…"],"year":2013,"numCitations":66,"pdf":"https://www.sciencedirect.com/science/article/pii/S2214109X1370072X","citationUrl":"http://scholar.google.com/scholar?cites=2604250749680421867&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:6wu_SEIoJCQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2604250749680421867&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Developing a model for an agile supply chain in pharmaceutical industry","url":"https://www.emerald.com/insight/content/doi/10.1108/IJPHM-09-2013-0050/full/html","authors":["G Mehralian","G Mehralian F Zarenezhad","G Mehralian F Zarenezhad AR Ghatari"],"year":2015,"numCitations":55,"pdf":"https://www.academia.edu/download/45847869/Developing_a_model_for_an_agile_supply_c20160522-12048-ir622t.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14817475164857239507&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:0wd99Sc_os0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14817475164857239507&hl=en&as_sdt=2005&sciodt=0,5","publication":"emerald.com"},{"title":"Does economic incentive matter for rational use of medicine? China's experience from the essential medicines program","url":"https://link.springer.com/content/pdf/10.1007/s40273-013-0068-z.pdf","authors":["M Chen","M Chen L Wang","M Chen L Wang W Chen","M Chen L Wang W Chen L Zhang","M Chen L Wang W Chen L Zhang H Jiang…"],"year":2014,"numCitations":51,"pdf":"https://www.researchgate.net/profile/Mingsheng_Chen2/publication/243968998_Does_Economic_Incentive_Matter_for_Rational_Use_of_Medicine_China's_Experience_from_the_Essential_Medicines_Program/links/56ad6d7c08ae43a3980c844f.pdf","citationUrl":"http://scholar.google.com/scholar?cites=4373200186256739809&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:4U2BMWa6sDwJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4373200186256739809&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer"}]}